Cite

HARVARD Citation

    Hirasawa, Y. et al. (2021). A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy. Medicine. 100 (23), p. . [Online]. 
  
Back to record